. This position also qualifies for the benefits detailed at the link provided below. Genentech is an equal opportunity employer. It...
. This position also qualifies for paid holiday time off benefits. Genentech is an equal opportunity employer. It is our policy...
we love. That’s what makes us Genentech, a member of the Roche Group. The Opportunity We are seeking a highly motivated... and creative Scientist 3 to join the Department of Antibody Engineering within Genentech Research and Early Development (gRED...
.D. degree), or in the final year of a Ph.D. program. The Opportunity: Genentech’s world-class biomedical research.... Genentech’s Postdoctoral Program will give you the chance to work on fundamental biomedical research questions. With an emphasis...
to align across internal stakeholders, including Genentech US Medical therapeutic area leaders, global medical leadership..., and capabilities across Genentech USM Build strong collaborative partnerships across therapeutic area leaders to drive alignment...
stewardship over Genentech’s multibillion-dollar campus redevelopment while serving as the organization’s primary authority... Governance, Stewardship & Clarity (Primary Leadership Focus): Policy Authority: Serve as the definitive authority on Genentech...
and procedures that govern the conduct of Genentech activities. The expected salary range for this position based on the primary... and responsibilities of the role. As a result, Genentech, Inc. (Company) from time to time will check your motor vehicle record...
within the Computational Sciences CoE at Genentech / Roche, dedicated to foundational machine learning research and the... by law. This position also qualifies for paid holiday time off benefits. Genentech is an equal opportunity employer. It...
also qualifies for the benefits detailed at the link provided below. #LI-PK1 Genentech is an equal opportunity employer. It...
Why Genentech We’re passionate about delivering on Our Promise to improve the lives of patients and create healthier... Area and Marketing Vision for Genentech Neurodegeneration (NDG) including promising, Phase 3 assets in Alzheimer’s Disease...